Day :
- Infection Treatment and Prevention Control | Pediatric Infections Prevention and Control | Resistance and Emerging Infectious Organisms | Infection Novel Therapies | Control of Zika/Malaria/Dengue Viral Infections | Hepatitis C | Surgical Infections Control | Control of HIV/AIDS from STDs & STIs | Antimicrobial Resistance| Microbial Pathogenesis
Chair
Paul Kadetz
Drew University, USA
Co-Chair
Saungi McCalla
White Plains Hospital, USA
Session Introduction
Saungi McCalla
White Plains Hospital, USA
Title: Automated hand hygiene compliance system associated with improved monitoring of hand hygiene
Time : 14:10-14:35
Biography:
Abstract:
Yaa Boateng-Marfo
National University of Singapore, Singapore
Title: Zein-loaded artemether nanoparticles for treatment of severe malaria
Time : 14:35-15:00
Biography:
Abstract:
Mohamed A Abouelkhair
University of Tennessee, USA
Title: Staphylococcus pseudintermedius adenosine synthase inhibits the innate immune response and promotes bacterial survival in canine blood
Time : 15:00-15:25
Biography:
Abstract:
Ruhul H Kuddus
Utah Valley University, Bangladesh
Title: Rapid changes in antibiotic sensitivity and resistance among pathogenic bacteria isolated from clinical samples in two hospitals in Dhaka City, Bangladesh
Time : 15:25-15:50
Biography:
Abstract:
Hafid Soualhine
National Public Health Institute of Quebec, Canada
Title: Spread of M. chimaera in cardiac surgery operating room in quebec: WGS and RTPCR for outbreak investigation and management
Time : 16:55-17:20
Biography:
Abstract:
Ibrahim Zeid
Hammoud Hospital University, Lebanon
Title: Using lean six sigma approach to reduce central line associated bloodstream infections in Hammoud hospital university medical center
Time : 17:20-17:45
Biography:
Abstract:
Shirley Gutkowski
Primal Air LLC, USA
Title: Improving breathing with a novel use of xylitol
Time : 17:45-18:10
Biography:
Abstract:
Abbas Ali Husseini
Ankara University, Turkey
Title: Seroepidemiology of HIV-1 and HTLV I\II in Afghanistan
Time : 18:10-18:35
Biography:
Abstract:
- Special Session
Session Introduction
Stef Stienstra
Armed forces of the Netherlands, Netherlands
Title: Zoonotic diseases threat needs sharing of information and new diagnostic systems in less developed countries
Biography:
Abstract:
- Microbial Infections | Infection Control and Hospital Epidemiology | Medical Microbiology | Immunity and Vaccination | Antimicrobial Resistance | Pediatric Infections Prevention and Control
Chair
Lia Monica Junie
Iuliu Hatieganu University of Medicine and Pharmacy, Romania
Session Introduction
Narveen Jandu
Gannon University, USA
Title: Application of online tools & resources on foodborne outbreaks for microbiology instruction
Time : 11:45-12:10
Biography:
Dr. Narveen Jandu is currently working as an assistant professor in the Gannon University, Pennsylvania, USA.
Abstract:
Pavithra Saikumar
University of Pacific, USA
Title: Prevalence of parasitic infection among school going children in south India
Time : 12:10-12:35
Biography:
Abstract:
Abbas Ali Husseini
Ankara University, Turkey
Title: Molecular Epidemiology of HBV, HCV and HDV in general population of Afghanistan
Time : 12:35-13:00
Biography:
Abstract:
Dhruv K. Mamtora
S. L. Raheja Hospital, India
Title: Lower limb deep tissue infections in type 2 diabetes patients at superspeciality tertiary care reference center in Mumbai
Time : 13:00-13:25
Biography:
Abstract:
Barley Chironda
Toronto East General hospital, Canada
Title: Implementation science a missing ingredient in healthcare surface disinfection
Time : 14:25-14:50
Biography:
Abstract:
Al dubisi Fatimah
University of Toronto, Canada
Title: Invasive streptococcal Pyogenes infection
Time : 14:50-15:15
Biography:
Abstract:
- Workshop
Session Introduction
Guy Hagues Fontaine
HDR Hôpital de la Salpêtrière, France
Title: Superimposed myocarditis can lead ARVD patients to acute progression to CHF
Biography:
Abstract:
- Video Presentation
Session Introduction
Zbigniew Pawlowski
Poznan University of Medical Sciences, Poland
Title: Taeniasis/neurocysticercosis control: Medical aspects
Time : 15:15-15:40
Biography:
Zbigniew Pawlowski is a Professor Emeritus of the Medical University in Poznan, Poland. He was a Chief of the Clinic of Parasitic and Tropical Medicine in Poznan (1970-1979 and 1987-1996) and an Organizer of the Intestinal Parasitic Infection Unit at World Health Organization in Geneva (1979-1986). He was active in several international parasitic and tropical medicine institutions (long term WHO expert, honorary member of several professional societies incl. American Society of Tropical Medicine and Hygiene). He has a DTMH diploma of the Liverpool School of Tropical Medicine (1964) and was for years involved in the Association of the Directors of the European Schools of Tropical Medicine. For almost three decades, he collaborated scientifically with the Centre for Disease Control in Atlanta, US. In 1999, he was awarded Doctor Honoris Causa by Warsaw Medical University.
Abstract:
Neurocysticercosis due to a larval stage of Taenia solium is a serious public health problem across low and middle-income countries of Latin America, Sub-Saharan Africa and Asia. It is a considerable problem in Europe and the United States, caused by immigration of T. solium carriers from endemic countries. Neurocysticercosis has a various clinical presentation, which ranges from asymptomatic infections to fatal cases. The most common symptoms are a late-onset epilepsy or partial seizures. The control of neurocysticercosis considers two aspects of T. solium transmission; it may be an indirect meat-born zoonotic control measure preventing human taeniosis by limitation of cysticercosis in pigs and a direct control measure by eradication of human tapeworm carriers, being the sole faecal-borne source of cysticercosis for humans and pigs. The control measures can be realized by the organized local or regional eradication programs as well as the routine daily medical and veterinary services. There is much progress in the veterinary control measures in endemic areas. However, the medical control of neurocysticercosis is still inadequately realized in spite of the improvements in diagnosis (fecal antigen tests), new taenicides (niclosamide, praziquantel) and better understood epidemiology (focality of transmission) of human T. solium taeniosis/cysticercosis. Several rules are proposed to be accepted in the medical control measures: Leaving untreated any detected case of T. solium taeniosis, spreading neurocysticercosis, is a medical error, due to difficulties in T. ,solium diagnosis the specific anthelminthic treatment has to be considered also in a suspected case of taeniosis (eg., there is a potential carrier of a T. solium tapeworm in every fourth case of neurocysticercosis), any Taenia tapeworm infection (T. solium, T. saginata, T. asiatica) deserves a specific treatment in order that T. solium is not missed, modern or traditional taenicides has to be easily available where needed, possibly free of charge, instruction has to be elaborated how to avoid the neurologic adverse reactions to praziquantel and preserve the stability and efficacy of niclosamide, a professional training in the control of taeniosis/neurocysticercosis has to be intensified in endemic areas, especially among mental health, public health and primary health care services as well as among veterinarians preventive screening of the T. solium tapeworm infected immigrants or visitors to endemic countries as well as local street meat vendors and specific treatment of those with a positive fecal antigen test, have to be considered.
Abdelhakam Hassan Ibrahim Ali
Neelain University, Sudan
Title: Carbapenemase production in hospital isolates of multidrug-resistant Klebsiella pneumoniae in Sudan
Time : 15:40-16:05
Biography:
Abdelhakam Hassan is a Technologist and is working as a Lecturer of Medical Microbiology (bacteriology, mycology, virology and molecular biology) who rapidly learnt all the aspects related to his study. He has more than four years' experiences in the field of drug resistance. He has done his MSc complementary research in the extended spectrum β-lactamase in K.pneumoniae (ESBL).
Abstract:
Background: Antibiotic non susceptible Bacteria have been increased and disseminated all over the world. So this resistant strain with treatment difficulty may threat the Patients lives. However the last line of treatment for such infection is antibiotic from Carbapenem family (1). One of the most virulence bacteria with pandrug resistant is Klebsiella pneumoniae which associated with high associated with morbidity and mortality (2). In this study, the phenotypic and genotypic features of carbapenem-resistant K.pneumoniae strains isolated in some Sudanese hospitals were studded.
Methodology: Strains of K. pneumoniae resistant to at least one carbapenem (imipenem or meropenem) were collected from May, 2015 to January, 2017. Isolates were obtained from clinical samples of patients treated inside the hospitals. Carbapenem resistance was confirmed using modified Hodge test (MHT) as phenotypic test and real-time PCR for genotypic detection.
Findings: A total 96 strains of K. pneumoniae of different non duplicated isolates were obtained from following samples; urine (47), wound swab (22), sputum (16), stool (3), CSF (1), HVS (4), seminal fluid (1), peritoneal (1) and blood.
All these isolates were found to be resistant to carbapenem by disc sensitivity test and modified Hodge test (MHT) revealed 63 (65.6%) isolates were carbapenemase producers. Seventy-two percent (70/96) isolates were positive for carbapenemase genes; 59.4% (57/96) were positive for blaKPC genes, 57.3% (55/96) were positive for blaNDM genes, 37.5% (36/96) were positive for blaVIM genes and 35.4% (34/96) were positive for blaOXA-48 genes. Nineteen isolates possessed four genes (blaKPC, blaNDM, blaVIM and blaOXA-48) , fourteen isolates possessed three genes{(blaNDM, blaVIM and blaOXA-48=6), (blaKPC, blaNDM, and blaOXA-48=3), (blaKPC, blaNDM and blaVIM =3), (blaKPC, blaVIM and blaOXA-48=2)}, 27 isolates possessed two genes{(blaKPC and blaNDM =21), (blaKPC, blaOXA-48=2), (blaNDM and blaVIM=3), (blaNDM and blaOXA-48=1)}, 10 isolates possessed only one gene (blaKPC=8, blaOXA-48=1 and blaVIM =1) and the remaining 26 isolates were free from these genes.
Conclusion & Recommendation: In Sudan, the most common type of carbapenemase gene multidrug-resistant K. pneumoniae is KPC. Co-production of KPC, VIM, NDM and OXA-48 genes are found in K. pneumoniae. To our knowledge, this study was done for the first time in Sudan. Therefore, it is necessary to determine carbapenem resistance in K.pneumoniae isolates and take essential infection control precautions to avoid spread of this resistance.